Dhoot Transmission IPO Details: Open Dates, Size, And What Investors Should Watch

Nidhi Thakur

August 10, 2026

Key Takeaways

Five IPOs are targeting Rs 7,443 crore in August's listing wave.
Dhoot Transmission IPO opens for subscription on August 10.
Molbio Diagnostics IPO, Milky Mist stock, and Shiprocket IPO News are key names to watch.
Leverage Swastika's Sarthi AI stock assistant for deeper, data-driven research.

In August, the Indian IPO market is buzzing with a wave of new listings that could collectively raise Rs 7,443 crore. Among them, the Dhoot Transmission IPO is one to watch as auto components makers step into public markets to fuel capacity expansion and R&D. The five-issuer lineup–Dhoot Transmission, Molbio Diagnostics, Milky Mist Dairy Food, Shiprocket, and Behari Lal Engineering–signals a busy week for retail investors scanning for growth and diversification. The issuances are scheduled across three days, with Molbio Diagnostics and Dhoot Transmission opening on August 10, Milky Mist following on August 11, and Shiprocket plus Behari Lal Engineering on August 12. This timeline gives investors multiple opportunities to participate in the IPO window and calibrate risk across different business models.

Dhoot Transmission IPO Details

The Dhoot Transmission IPO is part of a broader Rs 7,443 crore fundraising across five issues. Dhoot Transmission operates in the auto components space and seeks capital to fund capacity expansion and future technology investments. The opening dates for the five issues are staged: Molbio Diagnostics and Dhoot Transmission open on August 10; Milky Mist Dairy Food opens on August 11; Shiprocket and Behari Lal Engineering open on August 12. This staged approach offers retail investors multiple entry points to participate in a single IPO week while evaluating diverse business models across consumer, healthcare, tech-enabled logistics, and manufacturing.

Investors should consider valuations, use of proceeds, and the post-listing outlook of each issuer. With a total pool of Rs 7,443 crore, allocation can be tight on some issues; stakeholders should evaluate price bands, grey market signals (where applicable), and the issuer's long-term growth plan before subscribing. It is prudent to build a structured plan: determine the maximum you are willing to invest per IPO, preferred sectors, and risk tolerance. A balanced approach helps you capture potential upside while avoiding over-concentration in a single issue.

Readers who want deeper, data-driven research can use Swastika's Sarthi AI stock assistant for a structured analysis of Dhoot Transmission IPO and its peers; The tool helps translate annual reports and prospectus metrics into actionable investment decisions. Swastika's Sarthi AI stock assistant offers an integrated view of growth drivers, risk factors, and valuation scenarios to support your subscription choices.

Download App Now

Molbio Diagnostics IPO

Molbio Diagnostics is described as a point-of-care diagnostics firm, with a focus on rapid testing solutions. The company’s IPO opens on August 10 alongside Dhoot Transmission, as part of the same wave of listings. Investors should assess Molbio’s revenue trajectory, pipeline, and any regulatory milestones that could influence adoption and expansion. Point-of-care diagnostics have drawn investor interest due to the growing demand for fast, decentralized testing solutions, particularly in emerging markets with expanding healthcare access. When comparing Molbio Diagnostics IPO with peers, consider the mix of healthcare benefits, competitive advantages, and potential margins.

As you evaluate Molbio Diagnostics IPO, remember that this sector can be sensitive to regulatory and reimbursement dynamics. Investors should review the prospectus for details on how Molbio intends to monetize its platforms and whether its revenue growth is sustainable as it scales. For a more structured assessment, Swastika's Sarthi AI stock assistant can provide scenario-driven insights into Molbio Diagnostics IPO outcomes. Swastika's Sarthi AI stock assistant can help compare Molbio Diagnostics with other healthcare tech listings.

Download App Now

Milky Mist Stock Price Outlook

Milky Mist Dairy Food is another marquee listing in the week’s lineup, opening on August 11. The Milky Mist stock price trajectory after listing will be an important indicator for investors seeking exposure to consumer staples backed by a strong regional brand. Dairy products and packaged foods demand can be resilient, but pricing, commodity costs, and distribution margins will influence margins and profit potential in the early years post-listing. Investors should analyze Milky Mist’s distribution network, product mix, and brand moat as part of the evaluation process. This stock could appeal to investors who want defensive exposure with growth upside from brand expansion and geographic diversification.

Shiprocket IPO News

Shiprocket is a Temasek-backed e-commerce enablement platform entering the public markets as part of this robust IPO wave. The Shiprocket IPO news cycle has highlighted its growth trajectory, technology-enabled logistics capabilities, and the opportunity to scale with merchants as e-commerce expands across India. Investors should evaluate Shiprocket’s revenue model, customer concentration, and unit economics in the context of a competitive logistics space. The prospectus will provide details on how Shiprocket funds expansion, product development, and go-to-market strategies–and what that implies for future profitability.

Frequently Asked Questions

What is the combined size of the five IPOs launching next week?

The five IPOs are targeting a combined issue size of Rs 7,443 crore.

When do the IPOs open for subscription?

Molbio Diagnostics and Dhoot Transmission open on August 10; Milky Mist Dairy Food opens on August 11; Shiprocket and Behari Lal Engineering open on August 12.

Which companies are part of the August IPO wave?

Dhoot Transmission, Molbio Diagnostics, Milky Mist Dairy Food, Shiprocket, and Behari Lal Engineering.

What should retail investors consider before subscribing to these IPOs?

Consider valuations, use of proceeds, pricing bands, post-listing outlook, and diversification within a risk framework.

Where can investors access in-depth, structured stock research for these IPOs?

Use Swastika's Sarthi AI stock assistant for data-driven, scenario-based research.

Conclusion

For the retail investor, this August IPO wave is a test of patience, discipline, and your readiness to diversify across sectors. The five issues–Dhoot Transmission, Molbio Diagnostics, Milky Mist Dairy Food, Shiprocket, and Behari Lal Engineering–collectively present a spectrum of risk and growth: from capital-intensive manufacturing to health-tech and consumer brands. The big takeaway is to subscribe only within your risk tolerance and to treat IPOs as a part of a broader, long-term plan rather than a one-off bet.

Open your trading and demat account here

Reference :

1 : Legal

DISCLAIMER:

^{The information contained herein are strictly confidential and are meant solely for the information of the recipient and shall not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written permission of Swastika Investmart Ltd. (“SIL”). The contents of this document are for information purpose only. This document is not an investment advice and must not alone be taken as the basis for an investment decision. Before taking any decision to invest, the recipient of this document must read carefully the Red Herring Prospectus (“RHP”) issued to know the details of IPO and various risks and uncertainties associated with the investment in the IPO of the Company. All recipients of this document must before acting on the given information/details, make their own investigation and apply independent judgment based on their specific investment objectives and financial position. They can also seek appropriate professional advice from their own legal and tax consultants, advisors, etc. to understand the risks and investment considerations arising from such investment. The investor should possess appropriate resources to analyze such investment and the suitability of such investment to such investor’s particular circumstances before making any decisions on the investment. The Investor shall be solely responsible for any action taken based on this document. SIL shall not be liable for any direct or indirect losses arising from the use of the information contained in this document and accept no responsibility for statements made otherwise issued or any other source of information received by the investor and the investor would be doing so at his/her/its own risk. The information contained in this document should not be construed as forecast or promise or guarantee or assurance of any kind. The investors are not being offered any assurance or guaranteed or fixed returns on their investments. The users of this document must bear in mind that past performances if any, are not indicative of future results. The actual returns on investment may be materially different than the past. Investments in Securities market products and instruments including in the IPO of the Company are highly risky and they are generally not an appropriate avenue for someone with limited resources/ limited investment and low risk tolerance. Such Investments are subject to market risks including, without limitation, price, volatility and liquidity and capital risks. Therefore, the users of this document must carefully consider all the information given in the RHP including the risks factors before making any investment in the Equity Shares of the Company.Swastika Investmart Ltd or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither Swastika Investmart Ltd nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. Swastika Investment Ltd may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the Subject Company or third party in connection with the Research Report.CORPORATE & ADMINISTRATIVE OFFICE - 48, Jaora Compound, M.Y.H. Road, Indore - 452 001 | Phone 0731 - 6644000 Compliance Officer: Dimple Soni. Email: compliance@swastika.co.in Phone: (0731) 6644 241 Swastika Investmart Limited, SEBI Reg. No. : NSE/BSE/MSEI: INZ000192732 Merchant Banking: INM000012102 Investment Adviser: INA000009843 MCX/NCDEX: INZ000072532 CDSL/NSDL: IN-DP-115-2015 RBI Reg. No.: B-03-00174 IRDA Reg. No.: 713. Research Analyst Registration Number: INH000024073}